Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to 0.36.

  • Immunocore Holdings' Equity Ratio rose 325.87% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year increase of 325.87%. This contributed to the annual value of 0.36 for FY2024, which is 4216.51% down from last year.
  • Immunocore Holdings' Equity Ratio amounted to 0.36 in Q3 2025, which was up 325.87% from 0.36 recorded in Q2 2025.
  • Immunocore Holdings' Equity Ratio's 5-year high stood at 0.64 during Q4 2022, with a 5-year trough of 0.35 in Q3 2024.
  • For the 4-year period, Immunocore Holdings' Equity Ratio averaged around 0.42, with its median value being 0.36 (2025).
  • Per our database at Business Quant, Immunocore Holdings' Equity Ratio tumbled by 4216.51% in 2024 and then surged by 325.87% in 2025.
  • Immunocore Holdings' Equity Ratio (Quarter) stood at 0.64 in 2022, then decreased by 3.97% to 0.62 in 2023, then plummeted by 42.17% to 0.36 in 2024, then rose by 0.66% to 0.36 in 2025.
  • Its Equity Ratio stands at 0.36 for Q3 2025, versus 0.36 for Q2 2025 and 0.37 for Q1 2025.